Pathobiology of Christianson syndrome: Linking disrupted endosomal-lysosomal function with intellectual disability and sensory impairments.


Journal

Neurobiology of learning and memory
ISSN: 1095-9564
Titre abrégé: Neurobiol Learn Mem
Pays: United States
ID NLM: 9508166

Informations de publication

Date de publication:
11 2019
Historique:
received: 01 12 2017
revised: 04 05 2018
accepted: 12 05 2018
pubmed: 18 5 2018
medline: 31 7 2020
entrez: 18 5 2018
Statut: ppublish

Résumé

Christianson syndrome (CS) is a recently described rare neurogenetic disorder presenting early in life with a broad range of neurological symptoms, including severe intellectual disability with nonverbal status, hyperactivity, epilepsy, and progressive ataxia due to cerebellar atrophy. CS is due to loss-of-function mutations in SLC9A6, encoding NHE6, a sodium-hydrogen exchanger involved in the regulation of early endosomal pH. Here we review what is currently known about the neuropathogenesis of CS, based on insights from experimental models, which to date have focused on mechanisms that affect the CNS, specifically the brain. In addition, parental reports of sensory disturbances in their children with CS, including an apparent insensitivity to pain, led us to explore sensory function and related neuropathology in Slc9a6 KO mice. We present new data showing sensory deficits in Slc9a6 KO mice, which had reduced behavioral responses to noxious thermal and mechanical stimuli (Hargreaves and Von Frey assays, respectively) compared to wild type (WT) littermates. Immunohistochemical and ultrastructural analysis of the spinal cord and peripheral nervous system revealed intracellular accumulation of the glycosphingolipid GM2 ganglioside in KO but not WT mice. This cellular storage phenotype was most abundant in neurons of lamina I-II of the dorsal horn, a major relay site in the processing of painful stimuli. Spinal cords of KO mice also exhibited changes in astroglial and microglial populations throughout the gray matter suggestive of a neuroinflammatory process. Our findings establish the Slc9a6 KO mouse as a relevant tool for studying the sensory deficits in CS, and highlight selective vulnerabilities in relevant cell populations that may contribute to this phenotype. How NHE6 loss of function leads to such a multifaceted neurological syndrome is still undefined, and it is likely that NHE6 is involved with many cellular processes critical to normal nervous system development and function. In addition, the sensory issues exhibited by Slc9a6 KO mice, in combination with our neuropathological findings, are consistent with NHE6 loss of function impacting the entire nervous system. Sensory dysfunction in intellectually disabled individuals is challenging to assess and may impair patient safety and quality of life. Further mechanistic studies of the neurological impairments underlying CS and other genetic intellectual disability disorders must also take into account mechanisms affecting broader nervous system function in order to understand the full range of associated disabilities.

Identifiants

pubmed: 29772390
pii: S1074-7427(18)30114-X
doi: 10.1016/j.nlm.2018.05.004
pmc: PMC6235725
mid: NIHMS1508301
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

106867

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD045561
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007288
Pays : United States
Organisme : NICHD NIH HHS
ID : U54 HD090260
Pays : United States

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Références

PLoS Genet. 2014 Sep 04;10(9):e1004580
pubmed: 25188300
Mol Aspects Med. 2013 Apr-Jun;34(2-3):236-51
pubmed: 23506868
Am J Med Genet A. 2010 Nov;152A(11):2775-83
pubmed: 20949524
Biochim Biophys Acta. 2009 Apr;1793(4):605-14
pubmed: 19046998
Mol Psychiatry. 2014 Mar;19(3):277-9
pubmed: 23508127
FEBS Lett. 2006 Feb 6;580(3):717-9
pubmed: 16413548
J Biol Chem. 2003 Aug 8;278(32):29496-501
pubmed: 12756243
Semin Cell Dev Biol. 2004 Aug;15(4):433-44
pubmed: 15207833
Mol Neurodegener. 2016 Sep 02;11(1):63
pubmed: 27590723
Biochemistry. 2011 Feb 1;50(4):443-50
pubmed: 21171650
Cancer Res. 1986 Aug;46(8):4116-20
pubmed: 3731079
Epilepsy Res. 2014 May;108(4):811-5
pubmed: 24630051
Ann N Y Acad Sci. 1998 Jun 19;845:188-99
pubmed: 9668352
J Am Acad Child Adolesc Psychiatry. 2010 Sep;49(9):898-905.e3
pubmed: 20732626
Am J Hum Genet. 2009 Mar;84(3):367-79
pubmed: 19268276
Am J Hum Genet. 2008 Apr;82(4):1003-10
pubmed: 18342287
J Invest Dermatol. 1981 Feb;76(2):119-25
pubmed: 7462673
PLoS One. 2014 Aug 07;9(8):e104458
pubmed: 25101983
J Cell Biol. 2012 Nov 26;199(5):723-34
pubmed: 23185029
eNeuro. 2017 Jan 17;4(6):
pubmed: 29349289
Mol Biol Cell. 2010 Apr 1;21(7):1293-304
pubmed: 20130086
Hum Mol Genet. 2010 Mar 1;19(5):837-47
pubmed: 20007718
Front Cell Neurosci. 2014 Jun 23;8:172
pubmed: 25002837
J Cell Biol. 1996 Apr;133(1):29-41
pubmed: 8601610
J Exp Neurosci. 2016 Apr 05;9(Suppl 2):81-91
pubmed: 27081317
Brain Res Bull. 1999 Aug;49(6):377-91
pubmed: 10483914
Nature. 1994 Dec 15;372(6507):669-72
pubmed: 7990957
J Med Genet. 2013 Dec;50(12):802-11
pubmed: 24123876
Clin Genet. 2013 Jun;83(6):596-7
pubmed: 22931061
Mol Psychiatry. 2001 Jan;6(1):13-34
pubmed: 11244481
Lancet Neurol. 2013 Jan;12(1):105-18
pubmed: 23237905
Mol Biol Cell. 2005 Mar;16(3):1396-405
pubmed: 15635088
Mol Psychiatry. 2006 Oct;11(10):934-53
pubmed: 16894395
Biochem Biophys Res Commun. 2009 Nov 6;389(1):122-7
pubmed: 19706290
Neuroscience. 2016 May 26;323:195-206
pubmed: 26037807
Nat Rev Neurosci. 2017 Mar;18(3):147-157
pubmed: 28179641
J Neuropathol Exp Neurol. 2009 Feb;68(2):125-35
pubmed: 19151629
Brain. 2010 May;133(Pt 5):1391-402
pubmed: 20395263
Mol Pain. 2016 May 04;12:
pubmed: 27145803
Brain Pathol. 1998 Jan;8(1):175-93
pubmed: 9458175
Hum Mol Genet. 2011 Sep 15;20(18):3632-41
pubmed: 21680558
Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1345-54
pubmed: 18821565
Neuropediatrics. 2014 Aug;45(4):247-51
pubmed: 24285247
Am J Physiol Cell Physiol. 2011 Dec;301(6):C1431-44
pubmed: 21881004
Neuron. 2013 Oct 2;80(1):97-112
pubmed: 24035762
Am J Med Genet B Neuropsychiatr Genet. 2011 Dec;156B(7):799-807
pubmed: 21812100
Biochem Soc Trans. 2010 Dec;38(6):1436-41
pubmed: 21118103
Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):E2334-42
pubmed: 22826245
Bull Soc Fr Dermatol Syphiligr. 1964 Mar-Apr;71:292-4
pubmed: 14188400
Brain Struct Funct. 2015 Nov;220(6):3673-82
pubmed: 25158900
J Exp Biol. 1992 Nov;172:39-45
pubmed: 1491231
Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10954-9
pubmed: 11005868
Mol Biol Cell. 2013 Nov;24(21):3435-48
pubmed: 24006492
Nat Genet. 2009 May;41(5):535-43
pubmed: 19377476
J Biol Chem. 2006 Oct 6;281(40):29817-29
pubmed: 16861220
Trends Neurosci. 2009 Dec;32(12):638-47
pubmed: 19782411
J Biol Chem. 2005 Jan 14;280(2):1561-72
pubmed: 15522866
Int J Mol Sci. 2015 Nov 18;16(11):27508-19
pubmed: 26593904
J Neurochem. 1994 May;62(5):1852-62
pubmed: 8158134
Biochim Biophys Acta. 2012 Feb;1823(2):534-43
pubmed: 22210050
Annu Rev Neurosci. 2006;29:325-62
pubmed: 16776589
J Cell Biol. 1995 Aug;130(4):821-34
pubmed: 7642700
Hum Mol Genet. 2013 Oct 1;22(19):3960-75
pubmed: 23727835
Neuron. 2000 Feb;25(2):345-57
pubmed: 10719890
Cold Spring Harb Perspect Biol. 2012 Mar 01;4(3):
pubmed: 22258914
Nat Genet. 1996 Aug;13(4):485-8
pubmed: 8696348
PLoS One. 2012;7(9):e45992
pubmed: 23049915
J Biol Chem. 2015 Feb 27;290(9):5311-27
pubmed: 25561733
J Autism Dev Disord. 2017 Feb;47(2):285-296
pubmed: 27830427
Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8425-30
pubmed: 15155903
Eur J Neurosci. 2018 Mar;47(6):592-601
pubmed: 28452081
Neuron. 2016 Dec 21;92(6):1279-1293
pubmed: 27916453
Biochim Biophys Acta. 2009 Apr;1793(4):726-36
pubmed: 19111580
J Biol Chem. 2010 Jul 2;285(27):20423-7
pubmed: 20430897
Acta Neuropathol. 2015 Sep;130(3):315-31
pubmed: 26210990
Philos Trans R Soc Lond B Biol Sci. 2013 Dec 02;369(1633):20130143
pubmed: 24298145
Am J Physiol Cell Physiol. 2002 May;282(5):C1031-41
pubmed: 11940519
Pediatr Neurol. 2015 Dec;53(6):527-31
pubmed: 26421989
Nat Rev Mol Cell Biol. 2003 Mar;4(3):202-12
pubmed: 12612639
J Neurosci. 2013 Jan 9;33(2):595-610
pubmed: 23303939
Pflugers Arch. 2004 Feb;447(5):549-65
pubmed: 12845533
Brain Struct Funct. 2014 Jul;219(4):1251-61
pubmed: 23644587
Brain. 2015 Aug;138(Pt 8):2147-60
pubmed: 26068709
Ann Neurol. 2014 Oct;76(4):581-93
pubmed: 25044251
Brain Dev. 2013 Feb;35(2):172-6
pubmed: 22541666
Neuropathol Appl Neurobiol. 2002 Oct;28(5):343-57
pubmed: 12366816
Cell Death Differ. 2006 Mar;13(3):404-14
pubmed: 16397581
Neurosci Biobehav Rev. 2016 Sep;68:563-574
pubmed: 27345143
Cogn Neuropsychiatry. 2006 May;11(3):219-32
pubmed: 17354069
Brain. 2011 Nov;134(Pt 11):3369-83
pubmed: 21964919
PLoS Genet. 2014 Feb 06;10(2):e1004081
pubmed: 24516396
Curr Opin Neurobiol. 2011 Feb;21(1):61-7
pubmed: 20810276
Cell Death Differ. 2006 Mar;13(3):385-92
pubmed: 16397584
Science. 2008 Jul 11;321(5886):218-23
pubmed: 18621663
Arch Plast Surg. 2016 Jan;43(1):95-7
pubmed: 26848454
Mol Pain. 2017 Jan;13:1744806916688902
pubmed: 28326932
Neuron. 2007 Jun 7;54(5):739-54
pubmed: 17553423
FEBS Lett. 2005 Oct 24;579(25):5501-6
pubmed: 16212960
Neurochem Res. 2012 Jun;37(6):1372-80
pubmed: 22484966
J Autism Dev Disord. 2008 Jan;38(1):127-37
pubmed: 17415630
Neurochem Int. 2014 Jul;73:192-203
pubmed: 24090639
J Biol Chem. 2008 Feb 15;283(7):4417-29
pubmed: 18057008
Science. 2004 Sep 24;305(5692):1972-5
pubmed: 15448273
Arch Neurol. 1990 Mar;47(3):349-55
pubmed: 2310319
Dev Neurobiol. 2010 Apr;70(5):271-88
pubmed: 20186709
Hum Genet. 2016 Aug;135(8):841-50
pubmed: 27142213
Hum Mol Genet. 2007 Jul 15;16(14):1682-98
pubmed: 17519220
Psychiatr Genet. 2010 Apr;20(2):73-81
pubmed: 20032819
Front Neurosci. 2017 Jan 05;10:601
pubmed: 28105001
Dis Model Mech. 2016 Jan;9(1):13-23
pubmed: 26515654
Am J Med Genet A. 2011 Nov;155A(11):2771-4
pubmed: 21932316
Am J Med Genet A. 2016 Aug;170(8):2103-10
pubmed: 27256868
BMJ Case Rep. 2017 Dec 22;2017:
pubmed: 29275387
Exp Cell Res. 2009 Oct 15;315(17):3014-27
pubmed: 19619532
Acta Neuropathol. 1993;85(2):175-84
pubmed: 8382896
Cell Tissue Res. 2009 Jun;336(3):349-84
pubmed: 19387688
Pediatr Res. 2014 Jan;75(1-2):217-26
pubmed: 24165736
J Neurosci. 2005 May 11;25(19):4868-78
pubmed: 15888662
Virus Res. 2015 Sep 2;207:69-75
pubmed: 25556124
J Med Genet. 2016 May;53(5):310-7
pubmed: 26993267
J Intellect Disabil Res. 2003 Nov;47(Pt 8):622-7
pubmed: 14641810
Neurobiol Aging. 2006 Jun;27(6):895-903
pubmed: 15979214
J Med Genet. 1999 Oct;36(10):759-66
pubmed: 10528855
Autism. 2015 May;19(4):387-99
pubmed: 24687688

Auteurs

Mallory Kerner-Rossi (M)

Dominick P. Purpura Dept. of Neuroscience, Rose F. Kennedy Intellectual and Developmental Disabilities Research Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

Maria Gulinello (M)

Dominick P. Purpura Dept. of Neuroscience, Rose F. Kennedy Intellectual and Developmental Disabilities Research Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA; IDDRC Behavioral Core Facility, Neuroscience Department, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

Steven Walkley (S)

Dominick P. Purpura Dept. of Neuroscience, Rose F. Kennedy Intellectual and Developmental Disabilities Research Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Electronic address: steve.walkley@einstein.yu.edu.

Kostantin Dobrenis (K)

Dominick P. Purpura Dept. of Neuroscience, Rose F. Kennedy Intellectual and Developmental Disabilities Research Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH